Showing results (181-190 of 324) with videos related to
Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.Nature Medicine|June 8, 2019
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patientsRyan J Sullivan, Omid Hamid, Rene Gonzalez, et al.Journal for Immunotherapy of Cancer|August 20, 2021
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanomaSapna P Patel, Gina R Petroni, Jason Roszik, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 22, 2013
Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responsesWynette M Dietz, Nicole E B Skinner, Sara E Hamilton, et al.Cancer|August 10, 2019
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanomaGustavo Schvartsman, Junsheng Ma, Roland L Bassett, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLsDan Li, Yufeng Li, Jessica A Hernandez, et al.Cancer Cell|May 1, 2018
A-to-I RNA Editing Contributes to Proteomic Diversity in CancerXinxin Peng, Xiaoyan Xu, Yumeng Wang, et al.Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitorsXuefeng Wang, Tingyi Li, Islam Eljilany, et al.Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 6, 2024
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods studyDanielle B Tometich, Carley Geiss, Melinda L Maconi, et al.Pageof 33